FindTrial
Sign In

Hypertension and its management through Ayurveda

A clinical study of Tagaradi Kwatha and Takra Amalki Shirodhara in the management of Uccha Rakta Chapa W.S.R. to Essential Hypertension - HTN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030331
Enrollment
40
Registered
2021-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: I10- Essential (primary) hypertension

Interventions

Intervention1: Tagaradi Kawath: Tagaradi Kawath 10 gm twice a day for 30 days. Intervention2: Tagaradi Kwatha: Group A-Tagaradi Kwatha 10 gm twice a day for 30 days. Intervention3: Tagaradi kwatha and

Sponsors

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Well clinically diagnosed and confirmed cases of primary Hypertension.

Exclusion criteria

Exclusion criteria: 1.Secondary Hypertension. 2.Age below 18 & above 70 years. 3.Very severe/Malignant Hypertension/Hypertensive crisis 4.Drug induced Hypertension. 5.Hypertension with complications. 6.Gestational Hypertension. 7.Patient with any other acute illness.

Design outcomes

Primary

MeasureTime frame
Improvement in subjective and objective parametersTimepoint: 1 month—

Secondary

MeasureTime frame
To find out the efficacy of the treatment in the both groupTimepoint: 1 month—

Countries

India

Contacts

Public ContactDr Preeti Prajapat

DSRRAU, Jodhpur

drpramodmishra4@gmail.com9001009793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026